'Medical ethics have prevailed': UVA hospital to phase out youth transgender treatments after Trump order

The medical center, an academic healthcare facility associated with the University of Virginia (UVA), has been offering transgender medical care to minors aged 11 to 25, including providing children with puberty blockers that delay sex-related physical changes and cross-sex hormones, like testosterone and estrogen.

"Common sense and medical ethics have prevailed," Virginia Gov. Glenn Youngkin, R-Va., wrote in a post on X. 

"I'm grateful to the University of Virginia Board of Visitors for its action today to stop harmful transgender treatments for minors and to transfer existing patients to other providers," Younkin added.

Under the new resolution, the UVA Hospital will no longer provide new patients who are minors with services related to sex, contraception, and referrals for gender-affirming surgeries and voice therapy, according to its website.

UVA Hospital affiliates currently receive over $100 million in federal funding each year from the National Institute of Health (NIH) and "a loss of such federal funding would jeopardize the financial viability of the University," according to the new resolution.

The UVA School of Medicine's funding increased from $155.1 million in 2022 to $174.2 million in 2023, the UVA reported in February, citing the Blue Ridge Institute for Medical Research.